WHO ICTRP trial
Study of AZD4017 on markers of bone turnover in post-menopausal osteopaenia
EUCTR2013-003387-32-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-003387-32-GB |
|---|---|
| Public title | Study of AZD4017 on markers of bone turnover in post-menopausal osteopaenia |
| Scientific title | Phase II Study Of The Impact Of AZD4017, A Selective 11b-HSD1 Inhibitor, On Biochemical Markers Of Bone Turnover In Post-Menopausal Osteopaenia - The impact of AZD4017 on bone turnover in post-menopausal osteopaenia |
| Primary sponsor | University of Birmingham |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom |
| Conditions | Post-menopausal Osteopaenia MedDRA version: 16.1 Level: PT Classification code 10049088 Term: Osteopenia System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Musculoskeletal… |
| Interventions | Product Name: AZD4017 Product Code: AZD4017 Pharmaceutical Form: Tablet INN or Proposed INN: AZD4017 (no INN) CAS Number: 1024033-43-9 Current Sponsor code: AZD4017 Concentration unit: mg milligram(s) Concentration number: 400… |
| Registration date | Jan 29, 2014 |
| Target size | 100 |
| Secondary IDs | OP1213 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: